Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

NCT05465174 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Craniopharyngioma, Child
Craniopharyngioma
Recurrent Craniopharyngioma

Interventions

DRUG: Tovorafenib

Sponsor

Sabine Mueller, MD, PhD

Collaborators

[object Object]